Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.5K
Overview
51.5K
DNA Base Pairing02:27

DNA Base Pairing

33.1K
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
33.1K
DNA Base Pairing02:27

DNA Base Pairing

32.2K
32.2K
Plasmids01:28

Plasmids

1.5K
Plasmids are extrachromosomal DNA molecules found in bacteria, archaea, and some eukaryotic microbes like yeast. These small, circular DNA structures typically contain fewer than 30 genes, although some may exist linearly. Plasmids vary in their number within a cell, known as copy number. Single-copy plasmids are present in one copy per cell and multi-copy plasmids are present in multiple copies, reaching over 100 copies per cell.Plasmids usually replicate independently of the chromosomal DNA...
1.5K
Base-pairing and DNA Repair02:27

Base-pairing and DNA Repair

93.3K
93.3K
Cancer Vaccines01:30

Cancer Vaccines

1.0K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel approach for vaccine delivery using mRNA lipid nanoparticles for <i>in vivo</i> production of monoclonal antibodies.

Molecular therapy. Nucleic acids·2026
Same author

The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications.

Viruses·2025
Same author

Methuselah proteins in Drosophila: Structural and evolutionary insights from mathematical genomics.

Biochemical and biophysical research communications·2025
Same author

Improved SARS-CoV-2 vaccine based on intranasally administered replicon RNA.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Viral Vector-Based Cancer Vaccines.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Immunobiology and immunotherapy of COVID-19.

Progress in molecular biology and translational science·2025

Related Experiment Video

Updated: Jan 28, 2026

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.6K

Plasmid DNA-based Alphavirus Vaccines.

Kenneth Lundstrom1

  • 1PanTherapeutics, 1095 Lutry, Switzerland. lundstromkenneth@gmail.com.

Vaccines
|March 13, 2019
PubMed
Summary
This summary is machine-generated.

Engineered alphavirus vectors offer superior transgene expression and potent immune responses for therapeutic applications. These advanced vectors, including DNA and RNA formats, demonstrate significant potential in tumor regression and protection against infectious diseases.

Keywords:
DNA vaccinesRNA repliconsalphaviruseslayered RNA/DNA vectorsprotection against tumor challenges and infectious agentsrecombinant particlestumor regression

More Related Videos

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
06:37

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

16.6K
Generation of Recombinant Influenza Virus from Plasmid DNA
11:31

Generation of Recombinant Influenza Virus from Plasmid DNA

Published on: August 3, 2010

32.1K

Related Experiment Videos

Last Updated: Jan 28, 2026

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.6K
Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
06:37

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

16.6K
Generation of Recombinant Influenza Virus from Plasmid DNA
11:31

Generation of Recombinant Influenza Virus from Plasmid DNA

Published on: August 3, 2010

32.1K

Area of Science:

  • Biotechnology
  • Virology
  • Immunology

Background:

  • Alphaviruses are versatile viral vectors utilized for high-level transgene expression.
  • Early applications involved replication-deficient alphavirus-based vectors in various cell types and in vivo.
  • Recent advancements include plasmid DNA-based delivery and expression systems.

Purpose of the Study:

  • To evaluate the efficacy of engineered alphavirus vectors for transgene expression and immunization.
  • To compare the immunogenicity of alphavirus DNA vectors with conventional plasmid DNA vectors.
  • To assess the protective potential of alphavirus vectors against infectious agents and tumor cells.

Main Methods:

  • Engineering of alphavirus-based vectors for transgene expression.
  • Utilizing recombinant replication-deficient particles, plasmid DNA, and RNA replicons.
  • Conducting immunization studies in animal models to assess tumor regression and protection against challenges.

Main Results:

  • Alphavirus vectors, particularly RNA/DNA layered ones, show superior transgene expression compared to conventional plasmids.
  • DNA-based alphavirus vectors require significantly less DNA (1000-fold) for similar immune responses.
  • Immunization with alphavirus particles, RNA replicons, and DNA vectors demonstrated protection against lethal challenges.

Conclusions:

  • Engineered alphavirus vectors are highly effective for transgene expression and eliciting robust immune responses.
  • Alphavirus DNA vectors offer a more efficient alternative to conventional DNA vaccines.
  • Alphavirus-based strategies show promise for cancer immunotherapy and infectious disease prevention.